Synapse Open Synapse
News

Cancer Vaccine Cuts the Risk of Melanoma Recurrence, Merck and Moderna Report

The New York Times ·

Merck and Moderna released detailed results on an experimental vaccine to treat the skin cancer.

Same story elsewhere

Latest from The New York Times